tetradecanoylphorbol acetate has been researched along with methylprednisolone in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almawi, WY; Hadro, ET; Strom, TB | 1 |
| Hammerschmidt, DE; Jacob, HS; Knabe, AC; Lamche, HR; Silberstein, PT; Thomas, DD | 1 |
| Cerami, A; Kinkhabwala, M; Sehajpal, P; Sharma, VK; Skolnik, E; Smith, D; Suthanthiran, M; Vlassara, H | 1 |
| Solomkin, JS; Tennenberg, SD | 1 |
| Denys, C; Dupont, E; Pereleux, A; Romasco, F; Schandene, L; Wybran, J | 1 |
| Carlson, RP; Chang, J; Lewis, AJ; O'Neill-Davis, L | 1 |
| Canham, EM; Harada, RN; McMurtry, IF; Repine, JE; Shoemaker, SA; Tate, RM | 1 |
| Fernandez, A; Kiefer, J; McConkey, DJ; Neamati, N; Wright, S | 1 |
| De Caterina, R; Giannessi, D; Paggiaro, PL; Parente, L; Sicari, R; Solito, E | 1 |
| McCabe, MJ; Orrenius, S | 1 |
| Bird, CC; Clarke, AR; Harrison, DJ; Hooper, ML; Morris, RG; Purdie, CA; Wyllie, AH | 1 |
| Okamoto, K; Sotomatsu, A; Tanaka, M; Yoshida, T | 1 |
| Chwalinska-Sadowska, H; Klimczak, E; Koc, A; Ksiezopolska-Pietrzak, K; Luszczykiewicz, G; Maslinski, W; Ziolkowska, M | 1 |
| Antal-Szalmás, P; Gergely, P; Kiss, E; Kovács, I; Lakos, G; Sipka, S; Szántó, S; Szegedi, G; Szucs, K | 1 |
| Chen, D; Namba, H; Nishizawa, S; Ohta, S; Yokota, N; Yokoyama, T | 1 |
| Chen, YZ; Jiang, CL; Liu, L; Liu, Y; Long, F; Sun, HW; Wang, YX; Zhou, J | 1 |
| Böhler, T; Budde, K; Glander, P; Gurragchaa, P; Kamar, N; Klupp, J; Neumayer, HH; Nolting, J; Reisener, K | 1 |
17 other study(ies) available for tetradecanoylphorbol acetate and methylprednisolone
| Article | Year |
|---|---|
Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function.
Topics: Antigens, Differentiation, T-Lymphocyte; Calcium; CD4 Antigens; CD8 Antigens; Cell Division; Dexamethasone; Gene Expression Regulation; Glucocorticoids; Humans; Immune Tolerance; In Vitro Techniques; Ionomycin; Leukocytes, Mononuclear; Methylprednisolone; Phytohemagglutinins; Protein Kinase C; Second Messenger Systems; Signal Transduction; T-Lymphocytes, Regulatory; Tetradecanoylphorbol Acetate | 1991 |
Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity. Studies using electron paramagnetic resonance.
Topics: Electron Spin Resonance Spectroscopy; Estrogens, Conjugated (USP); Granulocytes; Humans; Ibuprofen; In Vitro Techniques; Membrane Fluidity; Methylprednisolone; Methylprednisolone Hemisuccinate; Tetradecanoylphorbol Acetate | 1990 |
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
Topics: Cyclosporins; Humans; Ionomycin; Lymphocyte Activation; Methylprednisolone; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1990 |
Surface receptor mobilization in complement-mediated neutrophil activation: characterization and effects of methylprednisolone.
Topics: Complement System Proteins; Humans; Lymphocyte Activation; Methylprednisolone; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Formyl Peptide; Receptors, Immunologic; Respiratory Distress Syndrome; Superoxides; Tetradecanoylphorbol Acetate | 1987 |
Lymphocyte activation mechanisms and in vitro actions of immunosuppressive drugs: a comparison.
Topics: Calcimycin; Cell Line; Cells, Cultured; Cyclosporins; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Mercaptopurine; Methylprednisolone; T-Lymphocytes, Cytotoxic; Tetradecanoylphorbol Acetate | 1987 |
Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Edema; Female; Lipoxygenase Inhibitors; Methylprednisolone; Mice; Mice, Inbred Strains; Otitis Externa; Pyrazoles; Tetradecanoylphorbol Acetate | 1985 |
Mepacrine but not methylprednisolone decreases acute edematous lung injury after injection of phorbol myristate acetate in rabbits.
Topics: Animals; Lung; Methylprednisolone; Neutrophils; Phorbols; Premedication; Pulmonary Edema; Quinacrine; Rabbits; Respiratory Distress Syndrome; Tetradecanoylphorbol Acetate | 1983 |
Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei.
Topics: Animals; Apoptosis; Calcium; CDC2 Protein Kinase; Cell Nucleus; DNA Damage; Lamin Type B; Lamins; Methylprednisolone; Mice; Mice, Inbred BALB C; Nuclear Proteins; Nucleosomes; Phosphotyrosine; Tetradecanoylphorbol Acetate; Thymus Gland; Time Factors; Tyrosine | 1995 |
Studies on the induction of lipocortin-1 by glucocorticoids.
Topics: Annexin A1; Bronchoalveolar Lavage Fluid; Cell Differentiation; Dexamethasone; Eicosanoids; Glucocorticoids; Humans; Leukemia, Promyelocytic, Acute; Macrophages, Alveolar; Methylprednisolone; Monocytes; Pneumonia; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II.
Topics: Apoptosis; Benzoquinones; Cells, Cultured; Chromatin; DNA Damage; Etoposide; Genistein; Humans; Immunophenotyping; Infant; Isoflavones; Kinetics; Lactams, Macrocyclic; Methylprednisolone; Novobiocin; Phorbol 12,13-Dibutyrate; Protein-Tyrosine Kinases; Quinones; Rifabutin; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymus Gland; Time Factors; Topoisomerase II Inhibitors | 1993 |
Thymocyte apoptosis induced by p53-dependent and independent pathways.
Topics: Animals; Apoptosis; Cells, Cultured; DNA; Etoposide; Female; Gamma Rays; Gene Deletion; Genes, p53; Heterozygote; Homozygote; Ionomycin; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Tetradecanoylphorbol Acetate; Thymus Gland | 1993 |
Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils.
Topics: Adult; Anti-Inflammatory Agents; Demyelinating Diseases; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neutrophils; Superoxides; Tetradecanoylphorbol Acetate | 1999 |
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cell Separation; Cells, Cultured; Cyclosporine; Humans; Interleukin-15; Interleukin-17; Interleukin-2; Ionomycin; Leukocytes, Mononuclear; Methylprednisolone; Middle Aged; Osteoarthritis; Phytohemagglutinins; Synovial Fluid; Tetradecanoylphorbol Acetate | 2000 |
Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Calcineurin; Case-Control Studies; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Ionophores; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Tetradecanoylphorbol Acetate | 2001 |
High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation.
Topics: Angiography; Animals; Anti-Inflammatory Agents; Basilar Artery; Disease Models, Animal; Disease Progression; Dogs; Dose-Response Relationship, Drug; Isometric Contraction; Methylprednisolone; Muscle, Smooth, Vascular; Potassium; Protein Kinase C; Subarachnoid Hemorrhage; Tetradecanoylphorbol Acetate; Vasoconstriction; Vasospasm, Intracranial | 2002 |
Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation.
Topics: Cell Degranulation; Gene Expression Regulation; Genomics; Glucocorticoids; Humans; Hydrocortisone; Methylprednisolone; Mifepristone; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tetradecanoylphorbol Acetate; Time Factors | 2005 |
Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.
Topics: Adult; Antigens, CD; Biomarkers; CD4-Positive T-Lymphocytes; Cell Proliferation; Concanavalin A; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Methylprednisolone; Middle Aged; Mycophenolic Acid; Receptors, Transferrin; Reproducibility of Results; Sirolimus; Tacrolimus; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2007 |